Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
J Breast Cancer ; 21(3): 334-338, 2018 Sep.
Article in English | MEDLINE | ID: mdl-30275863

ABSTRACT

Robotic surgical systems enhance surgical accuracy and efficiency by applying advanced technologies such as artificial arm joints to provide higher degrees of freedom of movement and high-quality three-dimensional images. However, the application of robotic surgical systems to breast surgery has not been widely attempted. The robotic system would improve cosmesis by enabling surgery using a single small incision. We report the first case of a gasless robot-assisted nipple-sparing mastectomy and immediate reconstruction in a patient with early breast cancer.

2.
J Nanosci Nanotechnol ; 13(1): 294-9, 2013 Jan.
Article in English | MEDLINE | ID: mdl-23646729

ABSTRACT

High efficiency blue organic light emitting diodes (OLEDs), based on 2-me-thyl-9,10-di(2-naphthyl) anthracene (MADN) doped with 4,4'-bis(9-ethyl-3-carbazovinylene)-1,1'-biphenyl (BCzVBi), were fabricated using two different electron transport layers (ETLs) of tris(8-hydroxyquinolino)-aluminum (Alq3) and 4,7-di-phenyl-1,10-phenanthroline (Bphen). Bphen ETL layers favored the efficient hole-electron recombination in the emissive layer of the BCzVBi-doped blue OLEDs, leading to high luminous efficiency and quantum efficiency of 8.34 cd/A at 100 mA/cm2 and 5.73% at 100 cd/m2, respectively. Maximum luminance of blue OLED with Bphen ETL and Alq3 ETL were 10670 cd/m2, and CIExy coordinates of blue OLEDs were (0.180, 0279) and (0.155, 0.212) at 100 cd/m2.


Subject(s)
Lighting/instrumentation , Semiconductors , Color , Electron Transport , Equipment Design , Equipment Failure Analysis , Fluorescence
3.
Opt Lett ; 37(24): 5235-7, 2012 Dec 15.
Article in English | MEDLINE | ID: mdl-23258063

ABSTRACT

High contrast blue organic light-emitting diodes were fabricated using an inorganic multilayer of NPB (700 Å)/MADN (200 Å)/Alq3 (300 Å)/LiF (10 Å)/Al (70 Å)/ZnSe (300 Å)/Al (1000 Å). The optical and electrical characteristics were measured and compared to conventional organic light-emitting devices (OLEDs) and OLEDs with polarizers. OLEDs with the metal multilayer cathodes had an improved contrast ratio of 135∶1 compared to 104∶1 for OLEDs with polarizers. In addition, the multilayer OLEDs had a low turn-on voltage of 3.5 V due to energy band fitting of ZnSe with Al and the electron transport layer.

4.
Exp Mol Med ; 40(3): 286-93, 2008 Jun 30.
Article in English | MEDLINE | ID: mdl-18587266

ABSTRACT

The purpose of this study was to identify the effect of sildenafil citrate on IL-1beta-induced nitric oxide (NO) synthesis and iNOS expression in human synovial sarcoma SW982 cells. IL-1? stimulated the cells to generate NO in both dose- and time-dependent manners. The IL-1beta-induced NO synthesis was inhibited by guanylate cyclase (GC) inhibitor, LY83583. When the cells were treated with 8-bromo-cGMP, a hydrolyzable analog of cGMP, NO synthesis was increased upto 5-fold without IL-1beta treatment suggesting that cGMP is an essential component for increasing the NO synthesis. Synoviocytes and chondrocytes contain strong cGMP phosphodiesterase (PDE) activity, which has biochemical features of PDE5. When SW982 cells were pretreated with sildenafil citrate (Viagra), a PDE5 specific inhibitor, sildenafil citrate significantly inhibited IL-1beta-induced NO synthesis and iNOS expressions. From this result, we noticed that PDE5 activity is required for IL-1?-induced NO synthesis and iNOS expressions in human synovial sarcoma cells, and sildenafil citrate may be able to suppress an inflammatory reaction of synovium through inhibition of NO synthesis and iNOS expression by cytokines.


Subject(s)
Interleukin-1beta/metabolism , Nitric Oxide Synthase Type II/biosynthesis , Nitric Oxide/biosynthesis , Phosphodiesterase Inhibitors/pharmacology , Piperazines/pharmacology , Sulfones/pharmacology , Anti-Inflammatory Agents/immunology , Anti-Inflammatory Agents/pharmacology , Cell Line, Tumor , Cyclic GMP/analogs & derivatives , Cyclic GMP/immunology , Cyclic GMP/metabolism , Cyclic Nucleotide Phosphodiesterases, Type 2/antagonists & inhibitors , Cyclic Nucleotide Phosphodiesterases, Type 2/metabolism , Humans , Male , Nitric Oxide/genetics , Nitric Oxide/immunology , Nitric Oxide Synthase Type II/genetics , Nitric Oxide Synthase Type II/immunology , Phosphodiesterase Inhibitors/immunology , Piperazines/immunology , Purines/immunology , Purines/pharmacology , Signal Transduction/drug effects , Signal Transduction/genetics , Signal Transduction/immunology , Sildenafil Citrate , Sulfones/immunology , Synovial Membrane/enzymology , Synovial Membrane/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...